| Year |
Citation |
Score |
| 2024 |
Hay ZLZ, Kim DD, Cimons JM, Knapp JR, Kohler ME, Quansah M, Zúñiga TM, Camp FA, Fujita M, Wang XJ, O'Connor BP, Slansky JE. Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity. Journal of Immunology (Baltimore, Md. : 1950). PMID 38416029 DOI: 10.4049/jimmunol.2300334 |
0.436 |
|
| 2023 |
Hay ZLZ, Knapp JR, Magallon RE, O'Connor BP, Slansky JE. Low TCR binding strength results in increased progenitor-like CD8+ tumor-infiltrating lymphocytes. Cancer Immunology Research. PMID 36787375 DOI: 10.1158/2326-6066.CIR-22-0761 |
0.565 |
|
| 2022 |
Camp FA, Brunetti TM, Williams MM, Christenson JL, Sreekanth V, Costello JC, Hay ZLZ, Kedl RM, Richer JK, Slansky JE. Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 T Cell Immunity. Cancers. 14. PMID 36139558 DOI: 10.3390/cancers14184397 |
0.481 |
|
| 2022 |
Wang Y, Tsitsiklis A, Devoe S, Gao W, Chu HH, Zhang Y, Li W, Wong WK, Deane CM, Neau D, Slansky JE, Thomas PG, Robey EA, Dai S. Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response. Frontiers in Immunology. 13: 847092. PMID 35967379 DOI: 10.3389/fimmu.2022.847092 |
0.455 |
|
| 2022 |
Hay ZLZ, Slansky JE. Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity. International Journal of Molecular Sciences. 23. PMID 35163755 DOI: 10.3390/ijms23031833 |
0.399 |
|
| 2021 |
Camp FA, Slansky JE. Implications of Antigen Selection on T Cell-Based Immunotherapy. Pharmaceuticals (Basel, Switzerland). 14. PMID 34681217 DOI: 10.3390/ph14100993 |
0.596 |
|
| 2021 |
Wei P, Jordan KR, Buhrman JD, Lei J, Deng H, Marrack P, Dai S, Kappler JW, Slansky JE, Yin L. Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34074778 DOI: 10.1073/pnas.2100588118 |
0.819 |
|
| 2021 |
Marín-Jiménez JA, Capasso A, Lewis MS, Bagby SM, Hartman SJ, Shulman J, Navarro NM, Yu H, Rivard CJ, Wang X, Barkow JC, Geng D, Kar A, Yingst A, Tufa DM, ... ... Slansky JE, et al. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes. Frontiers in Immunology. 12: 607282. PMID 33854497 DOI: 10.3389/fimmu.2021.607282 |
0.43 |
|
| 2020 |
Jordan K, Sikora MJ, Slansky JE, Minic A, Richer JK, Moroney MR, Hu J, Wolsky RJ, Watson ZL, Yamamoto TM, Costello JC, Clauset A, Behbakht K, Kumar TR, Bitler BG. The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32928797 DOI: 10.1158/1078-0432.Ccr-20-1762 |
0.684 |
|
| 2020 |
Katz SC, Moody AE, Guha P, Hardaway JC, Prince E, LaPorte J, Stancu M, Slansky JE, Jordan KR, Schulick RD, Knight R, Saied A, Armenio V, Junghans RP. HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery. Journal For Immunotherapy of Cancer. 8. PMID 32843493 DOI: 10.1136/Jitc-2020-001097 |
0.774 |
|
| 2020 |
Hoffmann MM, Slansky JE. T-cell receptor affinity in the age of cancer immunotherapy. Molecular Carcinogenesis. PMID 32386086 DOI: 10.1002/Mc.23212 |
0.557 |
|
| 2020 |
Slansky JE, Nakayama M. Peptide mimotopes alter T cell function in cancer and autoimmunity. Seminars in Immunology. 101395. PMID 32205022 DOI: 10.1016/J.Smim.2020.101395 |
0.561 |
|
| 2019 |
Westrich JA, Vermeer DW, Silva A, Bonney S, Berger JN, Cicchini L, Greer RO, Song JI, Raben D, Slansky JE, Lee JH, Spanos WC, Pyeon D. CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8 T-cell responses by upregulating MHC-I expression. Oncogene. PMID 31417179 DOI: 10.1038/S41388-019-0911-6 |
0.568 |
|
| 2019 |
Rabe JL, Gardner L, Hunter R, Fonseca JA, Dougan J, Gearheart CM, Leibowitz MS, Lee-Miller C, Baturin D, Fosmire SP, Zelasko SE, Jones CL, Slansky JE, Rupji M, Dwivedi B, et al. IL-12 abrogates calcineurin-dependent immune evasion during leukemia progression. Cancer Research. PMID 31142509 DOI: 10.1158/0008-5472.Can-18-3800 |
0.374 |
|
| 2019 |
Slansky JE, Spellman PT. Alternative Splicing in Tumors - A Path to Immunogenicity? The New England Journal of Medicine. 380: 877-880. PMID 30811916 DOI: 10.1056/Nejmcibr1814237 |
0.565 |
|
| 2019 |
Capasso A, Lang J, Pitts TM, Jordan KR, Lieu CH, Davis SL, Diamond JR, Kopetz S, Barbee J, Peterson J, Freed BM, Yacob BW, Bagby SM, Messersmith WA, Slansky JE, et al. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts. Journal For Immunotherapy of Cancer. 7: 37. PMID 30736857 DOI: 10.1186/S40425-019-0518-Z |
0.712 |
|
| 2018 |
Greene LI, Bruno TC, Christenson JL, D'Alessandro A, Culp-Hill R, Torkko K, Borges VF, Slansky JE, Richer JK. A Role for Tryptophan-2,3-dioxygenase in CD8 T Cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma. Molecular Cancer Research : McR. PMID 30143553 DOI: 10.1158/1541-7786.Mcr-18-0362 |
0.434 |
|
| 2018 |
Vartuli RL, Zhou H, Zhang L, Powers RK, Klarquist J, Rudra P, Vincent MY, Ghosh D, Costello JC, Kedl RM, Slansky JE, Zhao R, Ford HL. Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation. The Journal of Clinical Investigation. PMID 29757193 DOI: 10.1172/Jci96784 |
0.502 |
|
| 2018 |
Rozanov DV, Rozanov ND, Chiotti K, Reddy A, Wilmarth PA, David LL, Cha SW, Woo S, Pevzner P, Bafna V, Burrows GG, Rantala JK, Levin T, Anur P, Johnson-Camacho K, ... ... Slansky JE, et al. MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection. Journal of Proteomics. PMID 29331515 DOI: 10.1016/J.Jprot.2018.01.004 |
0.425 |
|
| 2017 |
Bruno TC, Ebner PJ, Moore BL, Squalls OG, Waugh KA, Eruslanov EB, Singhal S, Mitchell JD, Franklin WA, Merrick DT, McCarter MD, Palmer BE, Kern JA, Slansky JE. Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non-small cell lung cancer patients. Cancer Immunology Research. PMID 28848053 DOI: 10.1158/2326-6066.Cir-17-0075 |
0.423 |
|
| 2017 |
Mitchell AM, Kaiser Y, Falta MT, Munson DJ, Landry LG, Eklund A, Nakayama M, Slansky JE, Grunewald J, Fontenot AP. Shared αβ TCR Usage in Lungs of Sarcoidosis Patients with Löfgren's Syndrome. Journal of Immunology (Baltimore, Md. : 1950). PMID 28827283 DOI: 10.4049/Jimmunol.1700570 |
0.405 |
|
| 2016 |
Waugh KA, Leach SM, Moore BL, Bruno TC, Buhrman JD, Slansky JE. Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model. Journal of Immunology (Baltimore, Md. : 1950). PMID 27371726 DOI: 10.4049/Jimmunol.1600589 |
0.835 |
|
| 2016 |
Munson DJ, Egelston CA, Chiotti KE, Parra ZE, Bruno TC, Moore BL, Nakano TA, Simons DL, Jimenez G, Yim JH, Rozanov DV, Falta MT, Fontenot AP, Reynolds PR, Leach SM, ... ... Slansky JE, et al. Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCR. Proceedings of the National Academy of Sciences of the United States of America. PMID 27307436 DOI: 10.1073/Pnas.1606994113 |
0.54 |
|
| 2016 |
Waugh KA, Leach SM, Slansky JE. Tolerance of Tumor-Specific T cells in Melanoma Metastases. Journal of Clinical & Cellular Immunology. 7. PMID 27213115 DOI: 10.4172/2155-9899.1000409 |
0.571 |
|
| 2016 |
Capasso A, Lang J, Pitts TM, Davis SL, Lieu CH, Bagby SM, Tan AC, Tentler JJ, Slansky JE, Pelanda R, Eckhardt SG. Abstract PR03: Characterizing the immune context of responses to immunotherapy in humanized patient derived xenograft models of CRC Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-Pr03 |
0.509 |
|
| 2016 |
Greene LI, Bruno TC, Rogers TJ, Slansky JE, Borges VF, Richer JK. Abstract B55: Suppression of CD8 T-cell activation by tryptophan catabolism in triple-negative breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B55 |
0.501 |
|
| 2015 |
Desch AN, Gibbings SL, Goyal R, Kolde R, Bednarek J, Bruno T, Slansky JE, Jacobelli J, Mason R, Ito Y, Messier E, Randolph GJ, Prabagar M, Atif SM, Segura E, et al. Flow Cytometric Analysis of Mononuclear Phagocytes in Non-diseased Human Lung and Lung-draining Lymph Nodes. American Journal of Respiratory and Critical Care Medicine. PMID 26551758 DOI: 10.1164/Rccm.201507-1376Oc |
0.336 |
|
| 2015 |
Waugh KA, Leach SM, Slansky JE. Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity. Vaccines. 3: 771-802. PMID 26393659 DOI: 10.3390/Vaccines3030771 |
0.489 |
|
| 2015 |
Bruno T, Ebner P, Moore B, Munson D, Mitchell J, Kern J, Vignali DA, Slansky J. Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors Journal For Immunotherapy of Cancer. 3. DOI: 10.1186/2051-1426-3-S2-P397 |
0.524 |
|
| 2015 |
Waugh KA, Leach S, Slansky JE. Abstract PR03: Determine a transcriptional mechanism novel to tumor infiltrating T cell dysfunction Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-Pr03 |
0.629 |
|
| 2015 |
Bruno TC, Moore BL, Munson DJ, Ebner P, Kern J, Slansky JE. Abstract 4064: Targeting the anti-tumor function of B cells in non-small cell lung cancer patient tumors Cancer Research. 75: 4064-4064. DOI: 10.1158/1538-7445.Am2015-4064 |
0.535 |
|
| 2014 |
Desch AN, Gibbings SL, Clambey ET, Janssen WJ, Slansky JE, Kedl RM, Henson PM, Jakubzick C. Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction. Nature Communications. 5: 4674. PMID 25135627 DOI: 10.1038/Ncomms5674 |
0.406 |
|
| 2014 |
Bruno TC, Munson D, Moore B, Waugh K, Kern J, Slansky JE. Abstract A11: The function of B cells in non-small cell lung cancer patients. Clinical Cancer Research. 20: A11-A11. DOI: 10.1158/1078-0432.14Aacriaslc-A11 |
0.595 |
|
| 2013 |
Buhrman JD, Jordan KR, Munson DJ, Moore BL, Kappler JW, Slansky JE. Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. The Journal of Biological Chemistry. 288: 33213-25. PMID 24106273 DOI: 10.1074/Jbc.M113.509554 |
0.871 |
|
| 2013 |
Buhrman JD, Slansky JE. Mimotope vaccine efficacy gets a "boost" from native tumor antigens. Oncoimmunology. 2: e23492. PMID 23734309 DOI: 10.4161/Onci.23492 |
0.868 |
|
| 2013 |
Buhrman JD, Jordan KR, U'ren L, Sprague J, Kemmler CB, Slansky JE. Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens. Cancer Research. 73: 74-85. PMID 23161490 DOI: 10.1158/0008-5472.Can-12-1005 |
0.822 |
|
| 2013 |
Slansky JE, Cohen JJ, Cambier JC. Integrated immunology in Colorado. Immunologic Research. 55: 1-2. PMID 22975788 DOI: 10.1007/S12026-012-8376-5 |
0.331 |
|
| 2013 |
Bruno TC, French JD, Jordan KR, Ramirez O, Sippel TR, Borges VF, Haugen BR, McCarter MD, Waziri A, Slansky JE. Influence of human immune cells on cancer: studies at the University of Colorado. Immunologic Research. 55: 22-33. PMID 22941561 DOI: 10.1007/S12026-012-8346-Y |
0.745 |
|
| 2013 |
Buhrman JD, Slansky JE. Improving T cell responses to modified peptides in tumor vaccines. Immunologic Research. 55: 34-47. PMID 22936035 DOI: 10.1007/S12026-012-8348-9 |
0.883 |
|
| 2013 |
Bruno TC, Kern J, Slansky JE. Abstract B39: Activated B cells infiltrate lung cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B39 |
0.52 |
|
| 2013 |
Slansky JE, Buhrman JD. Abstract B29: Improving the identification of beneficial mimotopes using a representative tumor-specific T cell receptor. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B29 |
0.875 |
|
| 2012 |
Jordan KR, Buhrman JD, Sprague J, Moore BL, Gao D, Kappler JW, Slansky JE. TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 61: 1627-38. PMID 22350070 DOI: 10.1007/S00262-012-1217-5 |
0.863 |
|
| 2012 |
Mitchell L, Dow SW, Slansky JE, Biller BJ. Induction of remission results in spontaneous enhancement of anti-tumor cytotoxic T-lymphocyte activity in dogs with B cell lymphoma Veterinary Immunology and Immunopathology. 145: 597-603. PMID 22293625 DOI: 10.1016/J.Vetimm.2012.01.006 |
0.596 |
|
| 2012 |
Olino K, Wada S, Edil BH, Pan X, Meckel K, Weber W, Slansky J, Tamada K, Lauer P, Brockstedt D, Pardoll D, Schulick R, Yoshimura K. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases. Annals of Surgical Oncology. 19: S597-607. PMID 21979110 DOI: 10.1245/S10434-011-2037-0 |
0.53 |
|
| 2012 |
Bruno TC, Kern J, Slansky JE. Abstract A5: Characterizing and targeting B cells in lung cancer patients Clinical Cancer Research. 18: A5-A5. DOI: 10.1158/1078-0432.12Aacriaslc-A5 |
0.514 |
|
| 2011 |
Kemmler CB, Clambey ET, Kedl RM, Slansky JE. Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses. Journal of Immunology (Baltimore, Md. : 1950). 187: 4431-9. PMID 21940675 DOI: 10.4049/Jimmunol.1101555 |
0.846 |
|
| 2010 |
Slansky JE, Jordan KR. The Goldilocks model for TCR-too much attraction might not be best for vaccine design. Plos Biology. 8. PMID 20856901 DOI: 10.1371/Journal.Pbio.1000482 |
0.782 |
|
| 2010 |
Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE. Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Proceedings of the National Academy of Sciences of the United States of America. 107: 4652-7. PMID 20133772 DOI: 10.1073/Pnas.0914879107 |
0.84 |
|
| 2009 |
Jordan KR, Crawford F, Kappler JW, Slansky JE. Vaccination of mice with baculovirus-infected insect cells expressing antigenic proteins. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 2.15. PMID 19347845 DOI: 10.1002/0471142735.Im0215S85 |
0.787 |
|
| 2008 |
McWilliams JA, Sullivan RT, Jordan KR, McMahan RH, Kemmler CB, McDuffie M, Slansky JE. Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine. 26: 1863-73. PMID 18329760 DOI: 10.1016/J.Vaccine.2008.01.052 |
0.784 |
|
| 2008 |
Jordan KR, McMahan RH, Oh JZ, Pipeling MR, Pardoll DM, Kedl RM, Kappler JW, Slansky JE. Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 180: 188-97. PMID 18097019 DOI: 10.4049/Jimmunol.180.1.188 |
0.856 |
|
| 2007 |
Yoshimura K, Laird LS, Chia CY, Meckel KF, Slansky JE, Thompson JM, Jain A, Pardoll DM, Schulick RD. Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells. Cancer Research. 67: 10058-66. PMID 17942940 DOI: 10.1158/0008-5472.Can-07-0573 |
0.582 |
|
| 2007 |
McMahan RH, Slansky JE. Mobilizing the low-avidity T cell repertoire to kill tumors. Seminars in Cancer Biology. 17: 317-29. PMID 17651986 DOI: 10.1016/J.Semcancer.2007.06.006 |
0.828 |
|
| 2006 |
McMahan RH, McWilliams JA, Jordan KR, Dow SW, Wilson DB, Slansky JE. Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. The Journal of Clinical Investigation. 116: 2543-51. PMID 16932807 DOI: 10.1172/Jci26936 |
0.881 |
|
| 2006 |
McWilliams JA, McGurran SM, Dow SW, Slansky JE, Kedl RM. A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model. Journal of Immunology (Baltimore, Md. : 1950). 177: 155-61. PMID 16785510 DOI: 10.4049/Jimmunol.177.1.155 |
0.704 |
|
| 2006 |
Crawford F, Jordan KR, Stadinski B, Wang Y, Huseby E, Marrack P, Slansky JE, Kappler JW. Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands. Immunological Reviews. 210: 156-70. PMID 16623770 DOI: 10.1111/J.0105-2896.2006.00365.X |
0.727 |
|
| 2006 |
Yoshimura K, Jain A, Allen HE, Laird LS, Chia CY, Ravi S, Brockstedt DG, Giedlin MA, Bahjat KS, Leong ML, Slansky JE, Cook DN, Dubensky TW, Pardoll DM, Schulick RD. Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes. Cancer Research. 66: 1096-104. PMID 16424046 DOI: 10.1158/0008-5472.Can-05-2307 |
0.597 |
|
| 2003 |
Slansky JE. Antigen-specific T cells: analyses of the needles in the haystack. Plos Biology. 1: E78. PMID 14691549 DOI: 10.1371/Journal.Pbio.0000078 |
0.317 |
|
| 2003 |
Jain A, Slansky JE, Matey LC, Allen HE, Pardoll DM, Schulick RD. Synergistic effect of a granulocyte-macrophage colony-stimulating factor-transduced tumor vaccine and systemic interleukin-2 in the treatment of murine colorectal cancer hepatic metastases. Annals of Surgical Oncology. 10: 810-20. PMID 12900373 DOI: 10.1245/Aso.2003.10.006 |
0.51 |
|
| 2003 |
Ercolini AM, Machiels JP, Chen YC, Slansky JE, Giedlen M, Reilly RT, Jaffee EM. Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 170: 4273-80. PMID 12682262 DOI: 10.4049/Jimmunol.170.8.4273 |
0.633 |
|
| 2003 |
Luznik L, Slansky JE, Jalla S, Borrello I, Levitsky HI, Pardoll DM, Fuchs EJ. Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras. Blood. 101: 1645-52. PMID 12406877 DOI: 10.1182/Blood-2002-07-2233 |
0.596 |
|
| 2003 |
Durakovic N, Slansky J, Pardoll D, Fuchs E, Luznik L. 99 Solid tumor vaccines elicit distinct immune responses from host versus donor T cells in mixed chimeras created by non-myeloablative allogeneic stem cell transplantation (NST) Biology of Blood and Marrow Transplantation. 9: 94-95. DOI: 10.1016/S1083-8791(03)80100-3 |
0.479 |
|
| 2001 |
O'Herrin SM, Slansky JE, Tang Q, Markiewicz MA, Gajewski TF, Pardoll DM, Schneck JP, Bluestone JA. Antigen-specific blockade of T cells in vivo using dimeric MHC peptide Journal of Immunology. 167: 2555-2560. PMID 11509595 DOI: 10.4049/Jimmunol.167.5.2555 |
0.584 |
|
| 2001 |
Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. The Journal of Experimental Medicine. 193: 839-46. PMID 11283156 DOI: 10.1084/Jem.193.7.839 |
0.481 |
|
| 2000 |
Slansky JE, Rattis FM, Boyd LF, Fahmy T, Jaffee EM, Schneck JP, Margulies DH, Pardoll DM. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex Immunity. 13: 529-538. PMID 11070171 DOI: 10.1016/S1074-7613(00)00052-2 |
0.668 |
|
| 1998 |
Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP. Direct visualization of antigen-specific T cells: HTLV-1 TAX11-19- specific CD8+ T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients Proceedings of the National Academy of Sciences of the United States of America. 95: 7568-7573. PMID 9636190 DOI: 10.1073/Pnas.95.13.7568 |
0.488 |
|
| 1998 |
Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8: 177-87. PMID 9491999 DOI: 10.1016/S1074-7613(00)80470-7 |
0.504 |
|
| Show low-probability matches. |